-
2
-
-
34249686631
-
Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21
-
T. Inagaki, P. Dutchak, and G. Zhao Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21 Cell. Metab. 5 2007 415 425
-
(2007)
Cell. Metab.
, vol.5
, pp. 415-425
-
-
Inagaki, T.1
Dutchak, P.2
Zhao, G.3
-
3
-
-
67649823642
-
FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response
-
M.J. Potthoff, T. Inagaki, and S. Satapati FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response Proc. Natl. Acad. Sci. U S A 106 2009 10853 10858
-
(2009)
Proc. Natl. Acad. Sci. U S A
, vol.106
, pp. 10853-10858
-
-
Potthoff, M.J.1
Inagaki, T.2
Satapati, S.3
-
4
-
-
34249711964
-
Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states
-
M.K. Badman, P. Pissios, and A.R. Kennedy Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states Cell. Metab. 5 2007 426 437
-
(2007)
Cell. Metab.
, vol.5
, pp. 426-437
-
-
Badman, M.K.1
Pissios, P.2
Kennedy, A.R.3
-
5
-
-
84874117479
-
High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: A 3-year prospective study in China
-
H. Li, K. Dong, and Q. Fang High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: a 3-year prospective study in China J. Hepatol. 58 2013 557 563
-
(2013)
J. Hepatol.
, vol.58
, pp. 557-563
-
-
Li, H.1
Dong, K.2
Fang, Q.3
-
6
-
-
77957359658
-
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
-
H. Li, Q. Fang, and F. Gao Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride J. Hepatol. 53 2010 934 940
-
(2010)
J. Hepatol.
, vol.53
, pp. 934-940
-
-
Li, H.1
Fang, Q.2
Gao, F.3
-
7
-
-
63849189712
-
Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity
-
M. Mraz, M. Bartlova, and Z. Lacinova Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity Clin. Endocrinol. (Oxf) 71 2009 369 375
-
(2009)
Clin. Endocrinol. (Oxf)
, vol.71
, pp. 369-375
-
-
Mraz, M.1
Bartlova, M.2
Lacinova, Z.3
-
8
-
-
68149091653
-
Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance
-
A.O. Chavez, M. Molina-Carrion, and M.A. Abdul-Ghani Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance Diabetes Care 32 2009 1542 1546
-
(2009)
Diabetes Care
, vol.32
, pp. 1542-1546
-
-
Chavez, A.O.1
Molina-Carrion, M.2
Abdul-Ghani, M.A.3
-
9
-
-
80053409251
-
Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes
-
W. Chen, R.L. Hoo, and M. Konishi Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes J. Biol. Chem. 286 2011 34559 34566
-
(2011)
J. Biol. Chem.
, vol.286
, pp. 34559-34566
-
-
Chen, W.1
Hoo, R.L.2
Konishi, M.3
-
10
-
-
70349324370
-
Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver
-
Y. Hotta, H. Nakamura, and M. Konishi Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver Endocrinology 150 2009 4625 4633
-
(2009)
Endocrinology
, vol.150
, pp. 4625-4633
-
-
Hotta, Y.1
Nakamura, H.2
Konishi, M.3
-
11
-
-
84863012022
-
FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis
-
F.M. Fisher, S. Kleiner, and N. Douris FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis Genes. Dev. 26 2012 271 281
-
(2012)
Genes. Dev.
, vol.26
, pp. 271-281
-
-
Fisher, F.M.1
Kleiner, S.2
Douris, N.3
-
12
-
-
84865741904
-
BetaKlotho is required for fibroblast growth factor 21 effects on growth and metabolism
-
X. Ding, J. Boney-Montoya, and B.M. Owen betaKlotho is required for fibroblast growth factor 21 effects on growth and metabolism Cell. Metab. 16 2012 387 393
-
(2012)
Cell. Metab.
, vol.16
, pp. 387-393
-
-
Ding, X.1
Boney-Montoya, J.2
Owen, B.M.3
-
13
-
-
34249697012
-
BetaKlotho is required for metabolic activity of fibroblast growth factor 21
-
Y. Ogawa, H. Kurosu, and M. Yamamoto BetaKlotho is required for metabolic activity of fibroblast growth factor 21 Proc. Natl. Acad. Sci. U S A 104 2007 7432 7437
-
(2007)
Proc. Natl. Acad. Sci. U S A
, vol.104
, pp. 7432-7437
-
-
Ogawa, Y.1
Kurosu, H.2
Yamamoto, M.3
-
14
-
-
0034333526
-
Molecular cloning and expression analyses of mouse betaklotho, which encodes a novel klotho family protein
-
S. Ito, S. Kinoshita, and N. Shiraishi Molecular cloning and expression analyses of mouse betaklotho, which encodes a novel klotho family protein Mech. Dev. 98 2000 115 119
-
(2000)
Mech. Dev.
, vol.98
, pp. 115-119
-
-
Ito, S.1
Kinoshita, S.2
Shiraishi, N.3
-
15
-
-
84920702690
-
Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients
-
J.M. Gallego-Escuredo, J. Gomez-Ambrosi, and V. Catalan Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients Int. J. Obes. (Lond) 39 2015 121 129
-
(2015)
Int. J. Obes. (Lond)
, vol.39
, pp. 121-129
-
-
Gallego-Escuredo, J.M.1
Gomez-Ambrosi, J.2
Catalan, V.3
-
16
-
-
78049297991
-
Obesity is a fibroblast growth factor 21 (FGF21)-resistant state
-
F.M. Fisher, P.C. Chui, and P.J. Antonellis Obesity is a fibroblast growth factor 21 (FGF21)-resistant state Diabetes 59 2010 2781 2789
-
(2010)
Diabetes
, vol.59
, pp. 2781-2789
-
-
Fisher, F.M.1
Chui, P.C.2
Antonellis, P.J.3
-
18
-
-
77950343252
-
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease
-
G.S. Hotamisligil Endoplasmic reticulum stress and the inflammatory basis of metabolic disease Cell 140 2010 900 917
-
(2010)
Cell
, vol.140
, pp. 900-917
-
-
Hotamisligil, G.S.1
-
19
-
-
84855966721
-
Role of endoplasmic reticulum stress in metabolic disease and other disorders
-
L. Ozcan, and I. Tabas Role of endoplasmic reticulum stress in metabolic disease and other disorders Annu Rev. Med. 63 2012 317 328
-
(2012)
Annu Rev. Med.
, vol.63
, pp. 317-328
-
-
Ozcan, L.1
Tabas, I.2
-
20
-
-
8944259440
-
Signals from the stressed endoplasmic reticulum induce C/EBP-homologous protein (CHOP/GADD153)
-
X.Z. Wang, B. Lawson, and J.W. Brewer Signals from the stressed endoplasmic reticulum induce C/EBP-homologous protein (CHOP/GADD153) Mol. Cell. Biol. 16 1996 4273 4280
-
(1996)
Mol. Cell. Biol.
, vol.16
, pp. 4273-4280
-
-
Wang, X.Z.1
Lawson, B.2
Brewer, J.W.3
-
21
-
-
57049111040
-
UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators
-
D.T. Rutkowski, J. Wu, and S.H. Back UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators Dev. Cell. 15 2008 829 840
-
(2008)
Dev. Cell.
, vol.15
, pp. 829-840
-
-
Rutkowski, D.T.1
Wu, J.2
Back, S.H.3
-
22
-
-
84874664386
-
Fibroblast growth factor 21 is induced by endoplasmic reticulum stress
-
F.G. Schaap, A.E. Kremer, and W.H. Lamers Fibroblast growth factor 21 is induced by endoplasmic reticulum stress Biochimie 95 2013 692 699
-
(2013)
Biochimie
, vol.95
, pp. 692-699
-
-
Schaap, F.G.1
Kremer, A.E.2
Lamers, W.H.3
-
23
-
-
84901784272
-
ATF4- and CHOP-dependent induction of FGF21 through endoplasmic reticulum stress
-
X.S. Wan, X.H. Lu, and Y.C. Xiao ATF4- and CHOP-dependent induction of FGF21 through endoplasmic reticulum stress Biomed. Res. Int. 2014 2014 807874
-
(2014)
Biomed. Res. Int.
, vol.2014
, pp. 807874
-
-
Wan, X.S.1
Lu, X.H.2
Xiao, Y.C.3
-
24
-
-
84908200877
-
Fibroblast growth factor 21 is regulated by the IRE1alpha-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis
-
S. Jiang, C. Yan, and Q.C. Fang Fibroblast growth factor 21 is regulated by the IRE1alpha-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis J. Biol. Chem. 289 2014 29751 29765
-
(2014)
J. Biol. Chem.
, vol.289
, pp. 29751-29765
-
-
Jiang, S.1
Yan, C.2
Fang, Q.C.3
-
25
-
-
20044374023
-
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
-
D.E. Kleiner, E.M. Brunt, and M. Van Natta Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
-
(2005)
Hepatology
, vol.41
, pp. 1313-1321
-
-
Kleiner, D.E.1
Brunt, E.M.2
Van Natta, M.3
-
26
-
-
34247200322
-
Non-alcoholic fatty liver disease in the Asia-Pacific region: Definitions and overview of proposed guidelines
-
S. Chitturi, G.C. Farrell, and E. Hashimoto Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines J. Gastroenterol. Hepatol. 22 2007 778 787
-
(2007)
J. Gastroenterol. Hepatol.
, vol.22
, pp. 778-787
-
-
Chitturi, S.1
Farrell, G.C.2
Hashimoto, E.3
-
27
-
-
64549104842
-
The use of animal models in the study of diabetes mellitus
-
A. Chatzigeorgiou, A. Halapas, and K. Kalafatakis The use of animal models in the study of diabetes mellitus In Vivo 23 2009 245 258
-
(2009)
Vivo
, vol.23
, pp. 245-258
-
-
Chatzigeorgiou, A.1
Halapas, A.2
Kalafatakis, K.3
-
28
-
-
5644231992
-
Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes
-
U. Ozcan, Q. Cao, and E. Yilmaz Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes Science 306 2004 457 461
-
(2004)
Science
, vol.306
, pp. 457-461
-
-
Ozcan, U.1
Cao, Q.2
Yilmaz, E.3
-
29
-
-
84861355961
-
Klotho coreceptors inhibit signaling by paracrine fibroblast growth factor 8 subfamily ligands
-
R. Goetz, M. Ohnishi, and X. Ding Klotho coreceptors inhibit signaling by paracrine fibroblast growth factor 8 subfamily ligands Mol. Cell. Biol. 32 2012 1944 1954
-
(2012)
Mol. Cell. Biol.
, vol.32
, pp. 1944-1954
-
-
Goetz, R.1
Ohnishi, M.2
Ding, X.3
-
30
-
-
34848869695
-
Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21
-
H. Kurosu, M. Choi, and Y. Ogawa Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21 J. Biol. Chem. 282 2007 26687 26695
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 26687-26695
-
-
Kurosu, H.1
Choi, M.2
Ogawa, Y.3
-
31
-
-
39149091423
-
FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho
-
A. Kharitonenkov, J.D. Dunbar, and H.A. Bina FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho J. Cell. Physiol. 215 2008 1 7
-
(2008)
J. Cell. Physiol.
, vol.215
, pp. 1-7
-
-
Kharitonenkov, A.1
Dunbar, J.D.2
Bina, H.A.3
-
32
-
-
79960726293
-
Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo
-
F.M. Fisher, J.L. Estall, and A.C. Adams Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo Endocrinology 152 2011 2996 3004
-
(2011)
Endocrinology
, vol.152
, pp. 2996-3004
-
-
Fisher, F.M.1
Estall, J.L.2
Adams, A.C.3
-
33
-
-
84865422329
-
TNF-alpha represses beta-klotho expression and impairs FGF21 action in adipose cells: Involvement of JNK1 in the FGF21 pathway
-
J. Diaz-Delfin, E. Hondares, and R. Iglesias TNF-alpha represses beta-klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway Endocrinology 153 2012 4238 4245
-
(2012)
Endocrinology
, vol.153
, pp. 4238-4245
-
-
Diaz-Delfin, J.1
Hondares, E.2
Iglesias, R.3
-
34
-
-
41649109108
-
BetaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c
-
M. Suzuki, Y. Uehara, and K. Motomura-Matsuzaka betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c Mol. Endocrinol. 22 2008 1006 1014
-
(2008)
Mol. Endocrinol.
, vol.22
, pp. 1006-1014
-
-
Suzuki, M.1
Uehara, Y.2
Motomura-Matsuzaka, K.3
-
35
-
-
84863338708
-
Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB
-
C. Yang, C. Jin, and X. Li Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB PLoS One 7 2012 e33870
-
(2012)
PLoS One
, vol.7
, pp. e33870
-
-
Yang, C.1
Jin, C.2
Li, X.3
|